For example, tests authorized for the screening of asymptomatic individuals without known exposure are listed with "screening" in the attribute column pooling, multi-analyte, saliva, home collection, and home testing are similarly listed. Tests available without a prescription include the attribute "DTC" (for direct-to-consumer home collection tests) or "OTC" (for over-the-counter at-home tests). Test attributes are listed in the "Attributes" column. These EUAs have been issued for each individual test with certain conditions of authorization required of the manufacturer and authorized laboratories. This table includes information about authorized SARS-CoV-2 molecular diagnostic tests. Individual EUAs for Molecular Diagnostic Tests for SARS-CoV-2 EUA for Molecular Diagnostic Tests for SARS-CoV-2 Developed And Performed By Laboratories Certified Under CLIA To Perform High Complexity Tests.Umbrella EUA for SARS-CoV-2 Molecular Diagnostic Tests for Serial Testing.Pooling and Serial Testing Amendment for Certain Molecular Diagnostic Tests for SARS-CoV-2.Individual EUAs for Molecular Diagnostic Tests for SARS-CoV-2.IVDs for Management of COVID-19 Patients.Serology and Other Adaptive Immune Response Tests for SARS-CoV-2.
Antigen Diagnostic Tests for SARS-CoV-2.In Vitro Diagnostic EUAs: Overview and Templates
0 kommentar(er)
